DCT Adoption Tracker: Top 3 clinical trial decentralisation trends in Q1 2022
Clinical Trials Arena updates its exclusive taxonomic review of decentralised clinical trials with a spotlight on notable shifts in the past quarter.
By
Follow @ajhillman_ddj
Andrew Hillman is a data journalist at GlobalData Media, specialising in healthcare and pharmaceutical coverage. He is a graduate of Birmingham City University's data journalism program and previously worked as an analyst and modeller in the emergency healthcare sector.
Clinical Trials Arena updates its exclusive taxonomic review of decentralised clinical trials with a spotlight on notable shifts in the past quarter.
By Andrew HillmanTrial activity is on course to recuperate in hypertension, respiratory tract infections next year.
By Andrew Hillman and Reynald CastañedaThe frequency of sentences related to big data between July 2020 and June 2021 was 71% higher than in…
By Andrew HillmanHealthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the…
By Andrew HillmanMentions of cybersecurity in the pharmaceutical industry fell 34% between the first and second quarters of 2021.
By Andrew HillmanDigitalization mentions within company filings in the pharmaceutical industry rose 19% between Q1 and Q2 of 2021.
By Andrew HillmanThe frequency of sentences related to robotics between July 2020 and June 2021 was 100% higher than in 2016.
By Andrew HillmanDespite a strong research response to Covid-19, the UK lags behind other countries for clinical trial activity recovery.
By Andrew HillmanLupin Ltd was the company that referred to artificial intelligence the most between July 2020 and June 2021.
By Andrew HillmanThank you for subscribing to Clinical Trials Arena